Axiom/Source Library
+ New intake
← Source Library

Sermorelin Acetate — Peptide Dosing Protocols reference

patient_educationexpert_opinion · status: needs_provider_review
Details
Author:
Citation:
Summary (generated — provider review required)

Sermorelin Peptide Dosing Guide: Nightly GHRH Schedule & Side Effects (2026) Shop Protocols Stacks A–Z Index Email Updates Home Protocols Sermorelin Peptide Dosing Guide: Protocol, Timing & Side Effects (2026) Protocol / Research Dosing Guide Sermorelin Peptide Dosing Guide: Protocol, Timing & Side Effects (2026) An evidence-based sermorelin protocol guide covering dosing structure, injection timing, cycle length, side effects, and GH/IGF-1 research context for this GHRH peptide. By Garret Grant · Founder & Lead Researcher · Last reviewed June 2026 · Share Supplier Pick Copy code PEPPAL Copy code PEPPAL Verified Supplier Verified Supplier Peptide Partners Sermorelin Supply View supply Table of Contents View Supplies Quick Start Dosing Protocol & Schedule Supplies Needed Reconstitution Guide Dosage Chart Mechanism Who Should Avoid It Side Effects & Safety Timeline & Monitoring Clinical Evidence Storage & Handling Troubleshooting Regulatory Status Sermorelin Comparisons Related Protocols Blood Tests FAQ References Sermorelin Quick Start Sermorelin is a small peptide that copies the first 29 amino acids of the body's natural growth hormone-releasing hormone (GHRH). It is also called GRF 1-29 or sermorelin acetate .

The original source document remains the source of truth. Generated summaries are not authoritative.

Linked assets (19) · phenotypes (0)

evidence_reference, dosing_reference, mechanism, safety_reference, monitoring_reference

Findings (185) · awaiting review (139)
dosing · pending
Follow-up Re-check IGF-1 and metabolic markers after 6-8 weeks or after meaningful dose changes.
dosing · pending
If a dose is missed, skip it and resume the next night - do not double up.
mechanism · pending
Receptor: GHRH receptor on p
dosing · pending
Sermorelin Peptide Dosing Guide: Nightly GHRH Schedule & Side Effects (2026) Shop Protocols Stacks A–Z Index Email Updates Home Protocols Sermorelin Peptide Dosing Guide: Protocol, Timing & Side Effects (2026) Protocol / Research Dosing Guide Sermorelin Peptide Dosing Guide: Protocol, Timing & Side Effects (2026) An evidence-based sermorelin protocol guide covering dosing structure, injection timing, cycle length, side effects, and GH/IGF-1 research context for this GHRH peptide.
dosing · pending
By Garret Grant · Founder & Lead Researcher · Last reviewed June 2026 · Share Supplier Pick Copy code PEPPAL Copy code PEPPAL Verified Supplier Verified Supplier Peptide Partners Sermorelin Supply View supply Table of Contents View Supplies Quick Start Dosing Protocol & Schedule Supplies Needed Reconstitution Guide Dosage Chart Mechanism Who Should Avoid It Side Effects & Safety Timeline & Monitoring Clinical Evidence Storage & Handling Troubleshooting Regulatory Status Sermorelin Comparisons Related Protocols Blood Tests FAQ References Sermorelin Quick Start Sermorelin is a small peptide that copies the first 29 amino acids of the body's natural growth hormone-releasing hormone (GHRH).
mechanism · pending
The short copy still fits the pituitary gland's GHRH receptor, so it can trigger a normal growth hormone (GH) pulse.
dosing · pending
Most research-context protocols use 200-300 mcg once a night, by subcutaneous injection, about 3
regulatory · pending
It was FDA-approved in 1990 as a diagnostic agent and again in 1997 as a treatment for childhood growth hormone deficiency (brand name Geref).
safety · pending
Serono Laboratories pulled it from the market in 2008 for manufacturing reasons, not safety reasons.
regulatory · pending
As of June 2026, sermorelin still sits in FDA 503A Category 1 , which means licensed compounding pharmacies can legally prepare it.
dosing · pending
Common dose 200-300 mcg subQ nightly.
dosing · pending
Titration usually starts at 100 mcg.
dosing · pending
Reconstitution 3 mL bacteriostatic (BAC) water in a 10 mg vial gives 3 units per 100 mcg on a U-100 insulin syringe.
regulatory · pending
Regulatory status 503A Category 1 in June 2026 - still legally compoundable.
regulatory · pending
Sermorelin has historical FDA approvals but no current branded product.
dosing · pending
relin Dosing Protocol & Schedule Sermorelin dosing in research-context protocols centers on nightly subcutaneous (subQ) injections before bed.
dosing · pending
The FDA-era label set adult-context dosing at 0.2-0.3 mg per day (200-300 mcg).
dosing · pending
Modern community protocols use a similar range, with some practitioners titrating up to 400-500 mcg in selected cases.
dosing · pending
Higher doses do not always produce a bigger GH pulse.
dosing · pending
That feedback caps how much GH a single sermorelin dose can release.
dosing · pending
Typical Titration Schedule Sermorelin titration framework (research-context reference, not medical advice) Phase Initiation Time Weeks 1-2 Dose nightly 100 mcg Notes Check for injection-site reactions and any sleep changes.
dosing · pending
Phase Standard Time Weeks 3-4 Dose nightly 200 mcg Notes Common starting therapeutic tier in practitioner protocols.
dosing · pending
Phase Optimization Time Weeks 5-8 Dose nightly 300 mcg Notes Often paired with IGF-1 and thyroid labs at the 6-week point.
dosing · pending
Phase Elevated Time Week 9+ Dose nightly 400-500 mcg Notes Higher end if response at 300 mcg is not enough.
dosing · pending
Phase Time Dose nightly Notes Initiation Weeks 1-2 100 mcg Check for injection-site reactions and any sleep changes.
dosing · pending
Standard Weeks 3-4 200 mcg Common starting therapeutic tier in practitioner protocols.
dosing · pending
imization Weeks 5-8 300 mcg Often paired with IGF-1 and thyroid labs at the 6-week point.
dosing · pending
Elevated Week 9+ 400-500 mcg Higher end if response at 300 mcg is not enough.
dosing · pending
These numbers come from FDA-era prescribing context for the 0.2-0.3 mg/day range and from published practitioner reviews.
dosing · pending
Adult anti-aging dosing was never validated by a large modern RCT.
dosing · pending
This is not a dosing recommendation.
dosing · pending
Dosing 30-60 minutes before bed lines sermorelin up with that pulse.
dosing · pending
Schedule Cycle length Pattern 3-6 months at a target dose Best for Most published practitioner reviews suggest reviewing labs at baseline, week 6, and week 12.
dosing · pending
rget dose Most published practitioner reviews suggest reviewing labs at baseline, week 6, and week 12.
monitoring · pending
Lab monitoring matters Standard practice is baseline labs (IGF-1 plus a thyroid panel), repeat at week 6, and again at week 12.
regulatory · pending
About 6.5% of FDA-era trial participants developed hypothyroidism, which is why thyroid checks were built into the original prescribing pattern.
dosing · pending
The math below assumes a default 10 mg sermorelin vial, 3 mL BAC water per vial, and 200 mcg per night.
dosing · pending
Sermorelin Vials (10 mg default) One 10 mg vial holds 50 doses of 200 mcg.
dosing · pending
Cycle length Planning note 4 weeks 1 vial 28 nights of 200 mcg from one vial.
dosing · pending
6 months 6 vials Six vials cover ~168 nightly doses across a 24-week cycle.
Processing

Processed into 31 searchable sections.